Healthcare Trust of America, INC.: management transactions · United States · SEC (Form 4)

About Healthcare Trust of America, INC.

Healthcare Trust of America, Inc. (HTA) was a U.S.-listed healthcare real estate investment trust focused on medical office buildings (MOBs). The company traded on the NYSE in the United States and built its business around a defensive property segment tied to long-term healthcare demand. HTA was organized in the early 2000s and, over time, assembled a large portfolio of properties designed to serve physicians, hospital systems, imaging centers, outpatient surgery providers, and other ambulatory care users. Prior to its combination with Healthcare Realty Trust, HTA described itself as the largest dedicated owner and operator of medical office buildings in the United States. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1360604/000136060422000014/hta-20211231.htm?utm_source=openai)) HTA’s operating model centered on owning and managing healthcare real estate, with properties located primarily on or adjacent to hospital campuses or in community-based outpatient locations. This location strategy is important because it supports sticky tenant relationships, long lease terms, and relatively resilient occupancy, given the operational link between MOBs and healthcare delivery. The company emphasized internal growth through proactive asset management, leasing, building services, and property management, while also targeting accretive acquisitions in markets with attractive demographics that complemented its existing footprint. Its tenant mix included health systems, academic and research institutions, and physician practices of various sizes. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1360604/000136060422000031/hta-20220331.htm?utm_source=openai)) Geographically, HTA had a broad U.S. footprint. SEC filings from 2022 indicate that its portfolio was spread across 32 states, highlighting diversification across multiple regional healthcare markets. This national presence helped HTA reduce reliance on any single local market and reinforced the company’s role as a scale platform in U.S. healthcare real estate. Earlier company disclosures also referenced a regional operating structure, underscoring a locally managed approach to leasing and asset oversight. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1360604/000136060422000031/hta-20220331.htm?utm_source=openai)) The most significant recent corporate event was the merger with Healthcare Realty Trust. The transaction was announced in February 2022 and completed in July 2022, creating the largest pure-play medical office building REIT in the U.S. That combination effectively ended HTA as a standalone listed company and integrated its portfolio into a larger healthcare real estate platform. For investors following SEC Form 4 insider activity, this historical context matters: HTA is best understood as a legacy healthcare REIT franchise whose assets and operating capabilities were absorbed into the combined Healthcare Realty structure. ([sec.gov](https://www.sec.gov/Archives/edgar/data/899749/000119312522055684/d323322dex991.htm?utm_source=openai)) From an investment perspective, HTA represented a classic defensive healthcare real estate profile: recurring rental income linked to essential medical services, broad tenant diversification, and exposure to a structurally supported asset class. For French, Belgian, and Swiss investors, the key takeaway is that HTA was a U.S.-based NYSE healthcare REIT whose value proposition lay in stable medical office real estate rather than in direct healthcare operations. At the same time, the sector remains sensitive to interest rates, capital markets, and REIT funding conditions. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1360604/000136060422000031/hta-20220331.htm?utm_source=openai))